CARDIAC ATTR AMYLOIDOSIS
Clinical trials for CARDIAC ATTR AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new CARDIAC ATTR AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for CARDIAC ATTR AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New imaging agent could spot hidden heart disease
Diagnosis Recruiting nowThis study tests whether a radioactive tracer called Florbetaben F18 can reliably detect amyloid deposits in the heart using PET scans. Researchers will scan 15 people with and without cardiac amyloidosis twice to see if the results are consistent. The goal is to improve diagnosi…
Matched conditions: CARDIAC ATTR AMYLOIDOSIS
Phase: PHASE1 • Sponsor: Lantheus Germany GmbH • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Heart scans aim to solve amyloidosis treatment mystery
Knowledge-focused Recruiting nowThis study looks at why about one-third of people with a heart condition called cardiac amyloidosis continue to get worse even with medication. Researchers will use special heart scans (ultrasound, MRI, and PET) at the start and after one year to see what is happening inside the …
Matched conditions: CARDIAC ATTR AMYLOIDOSIS
Phase: NA • Sponsor: Dominik Benz • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC